Arm
- The verdict: deteriorating revenue quality, related party risks (Arm China and SoftBank), ballooning stock compensation expense, rich valuation.
- Moat: an instruction set is a standard protected by the software written against them.
- Business mix: Hyperscaler capex offsetting a shrinking third-party license book and a flat handset market. ARM's expansion into chip manufacturing is an exchange of margin for scale.
- Growth drivers: royalty rate per chip through Armv9 and CSS adoption + data center penetration.
- Risks:
- Valuation appears rich.
- Small float -> Volatile prices
- Revenue quality is deteriorating beneath a growing headline. Third-party license revenue falling. Annualized contract value growth slowing.
- Governance: No control over the two largest revenue concentrations (China and SoftBank)
- China risk (16% of revenue). No control or audit, in a jurisdiction actively promoting RISC-V as a sovereign alternative.
- SoftBank holds 86%. Potential conflict. Limited influence with minority shareholders.
- Selling its own chips carries the risk of execution including capacity ramp and gating, working capital drag, and alienating the licensing customers.
- Stock compensation consumes the operating profit.
Reports
